These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38246517)

  • 21. Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI.
    Barentsz MW; Taviani V; Chang JM; Ikeda DM; Miyake KK; Banerjee S; van den Bosch MA; Hargreaves BA; Daniel BL
    J Magn Reson Imaging; 2015 Dec; 42(6):1656-65. PubMed ID: 25914178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
    Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
    J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of malignant and benign breast lesions: Added value of the qualitative analysis of breast lesions on diffusion-weighted imaging (DWI) using readout-segmented echo-planar imaging at 3.0 T.
    An YY; Kim SH; Kang BJ
    PLoS One; 2017; 12(3):e0174681. PubMed ID: 28358833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings.
    Tudorica LA; Oh KY; Roy N; Kettler MD; Chen Y; Hemmingson SL; Afzal A; Grinstead JW; Laub G; Li X; Huang W
    Magn Reson Imaging; 2012 Nov; 30(9):1257-67. PubMed ID: 22770687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast.
    Ao F; Yan Y; Zhang ZL; Li S; Li WJ; Chen GB
    Acta Radiol; 2022 Jul; 63(7):891-900. PubMed ID: 34134527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.
    Kul S; Cansu A; Alhan E; Dinc H; Gunes G; Reis A
    AJR Am J Roentgenol; 2011 Jan; 196(1):210-7. PubMed ID: 21178069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
    Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
    Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial Intelligence-Based Classification of Breast Lesions Imaged With a Multiparametric Breast MRI Protocol With Ultrafast DCE-MRI, T2, and DWI.
    Dalmiş MU; Gubern-Mérida A; Vreemann S; Bult P; Karssemeijer N; Mann R; Teuwen J
    Invest Radiol; 2019 Jun; 54(6):325-332. PubMed ID: 30652985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.
    Spick C; Bickel H; Pinker K; Bernathova M; Kapetas P; Woitek R; Clauser P; Polanec SH; Rudas M; Bartsch R; Helbich TH; Baltzer PA
    NMR Biomed; 2016 Oct; 29(10):1445-53. PubMed ID: 27553252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
    Kuang F; Yan Z; Li H; Feng H
    J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of DCE-MRI, multiparametric MRI and multimodality imaging for discrimination of breast non-mass-like enhancement lesions.
    Zang H; Liu HL; Zhu LY; Wang X; Wei LM; Lou JJ; Zou QG; Wang SQ; Wang SJ; Jiang YN
    Br J Radiol; 2022 Aug; 95(1136):20220211. PubMed ID: 35522775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
    Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
    J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additional value of diffusion-weighted imaging to evaluate multifocal and multicentric breast cancer detected using pre-operative breast MRI.
    Song SE; Park EK; Cho KR; Seo BK; Woo OH; Jung SP; Cho SB
    Eur Radiol; 2017 Nov; 27(11):4819-4827. PubMed ID: 28593433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of synthetic diffusion-weighted imaging on breast magnetic resonance imaging assessment: comparison with conventional diffusion-weighted imaging.
    Yılmaz E; Güldoğan N; Ulus S; Türk EB; Mısır ME; Arslan A; Arıbal ME
    Diagn Interv Radiol; 2024 Mar; 30(2):91-98. PubMed ID: 37888786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
    Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
    Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.